Skip to main content

Advertisement

SpringerLink
Log in

Vulvar Lichen Sclerosus in the Elderly

Pathophysiology and Treatment Update

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Lichen sclerosus is a chronic skin condition that most commonly affects the anogenital skin of postmenopausal women. The aetiology of the condition is multifactorial. The most common presenting symptom is itching. Lichen sclerosus has a characteristic appearance. Diagnosis is made with vulvar biopsy. Treatment is important and the regimen most often includes topical corticosteroid ointments. Lifetime surveillance of the skin is imperative because of the increased risk of squamous cell carcinoma in patients with lichen sclerosus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Summers PR, Hunn J. Unique dermatologic aspects of the postmenopausal vulva. Clin Obstet Gynecol 2007 Sep; 50(3): 745–51

    Article  PubMed  Google Scholar 

  2. Hallopeau H. Du lichen plan, et particulierement de sa forme atrophique. Un Med (Par) 1887; 43: 729–3

    Google Scholar 

  3. Darier J. Lichen plan sclereux. Ann Dermatol Syph 1892; 3: 833–7

    Google Scholar 

  4. Friedrich EG. Lichen sclerosus. J Reprod Med 1976; 17: 147–54

    PubMed  Google Scholar 

  5. Jones RW, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008; 198: 496, E1-3

    Article  PubMed  Google Scholar 

  6. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol 2005; 48: 808–17

    Article  PubMed  Google Scholar 

  7. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353: 1777–83

    Article  PubMed  CAS  Google Scholar 

  8. Leibovitz A, Kaplun V, Saposhnicov N, et al. Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr 2000; 31: 1–4

    Article  PubMed  Google Scholar 

  9. Meyrick TRH, Ridley CM, McGibbon DH, et al. Anogenital lichen sclerosus in women. JR Soc Med 1996; 89: 694–8

    Google Scholar 

  10. Meyrick TRH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity: a study of 350 women. Br J Dermatol 1988; 118: 41–6

    Article  Google Scholar 

  11. Clark JA, Muller SA. Lichen sclerosus et atrophicus in children. Arch Dermatol 1967; 95: 476–82

    Article  PubMed  CAS  Google Scholar 

  12. Smith YR, Haefner HK. Vulvar lichen sclerosus: pathophysiology and treatment. Am J Clin Dermatol 2004; 5(2): 105–25

    Article  PubMed  Google Scholar 

  13. Cooper SM, Ali I, Baldo M, et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008 Nov; 144(11): 1432–5

    Article  PubMed  Google Scholar 

  14. Goolamali SK, Barnes EW, Irvine WJ, et al. Organ specific antibodies in patients with lichen sclerosus. Br Med J 1974; 4(5936): 78–9

    Article  PubMed  CAS  Google Scholar 

  15. Birenbaum DL, Young RC. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med 2007 Jan; 52(1): 28–30

    PubMed  Google Scholar 

  16. Simpkin S, Oakley A. Clinical review of 202 patients with vulval lichen sclerosus: a possible association with psoriasis. Aust J Dermatol 2007 Feb; 48(1): 28–31

    Article  Google Scholar 

  17. Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132: 197–203

    Article  PubMed  CAS  Google Scholar 

  18. Howard A, Dean D, Cooper S, et al. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Aust J Dermatol 2004 Feb; 45(1): 12–5

    Article  Google Scholar 

  19. Friedrich Jr EG, Kalra PS. Serum levels of sex hormones in vulval lichen sclerosus and the effect of topical testosterone. NEJM 1984; 310: 488–91

    Article  PubMed  Google Scholar 

  20. Kohlberger PD, Joura EA, Bancher D, et al. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Investig 1998 Nov-Dec; 5(6): 331–3

    Article  PubMed  CAS  Google Scholar 

  21. Taylor AH, Guzail M, Al-Azzawi F. Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis. Br J Dermatol 2008 Feb; 158(2): 319–28

    Article  PubMed  CAS  Google Scholar 

  22. Eisendle K, Grabner T, Kutzner H, et al. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol 2008; 144(5): 662–3

    Article  Google Scholar 

  23. Karram M, Tabor B, Smotkin D, et al. Detection of human papillomavirus deoxyribonucleic acid from vulvar dystrophies and vulvar intraepithelial neoplastic lesions. Am J Obstet Gynecol 1988; 159: 22–3

    PubMed  CAS  Google Scholar 

  24. Neill SM, Leibowitch M, Pelisse M. Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus. Am J Obstet Gynecol 1990; 162: 1633–4

    PubMed  CAS  Google Scholar 

  25. van Seters M, ten Kate FJ, van Beurden M, et al. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. J Clin Pathol 2007 May; 60(5): 504–9

    Article  PubMed  Google Scholar 

  26. Milligan A, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus following sunburn. Clin Exp Dermatol 1988; 13: 36–7

    Article  PubMed  CAS  Google Scholar 

  27. Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol 1985; 121: 1044–7

    Article  PubMed  CAS  Google Scholar 

  28. Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362: 118–23

    Article  PubMed  CAS  Google Scholar 

  29. Rodke G, Friedrich Jr EG, Wilkinson EJ. Malignant potential of mixed vulvar dystrophy lichen sclerosus associated with squamous cell hyperplasia. J Reprod Med 1988; 33: 545–50

    PubMed  CAS  Google Scholar 

  30. Slater DN, Wagner BE. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2007 Feb; 50(3): 388–9; author reply 389–91

    Article  PubMed  CAS  Google Scholar 

  31. Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005 Nov; 50(11): 807–10

    PubMed  Google Scholar 

  32. Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2005 Oct; 47(4): 340–7

    Article  PubMed  CAS  Google Scholar 

  33. Cooper SM, Gao XH, Powell JJ, et al. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004 Jun; 140(6): 702–6

    Article  PubMed  CAS  Google Scholar 

  34. Neill SM, Tatnall FM, Cox NH. British Association of Dermatologists. Guidelines for the management of lichen sclerosus. Br J Dermatol 2005 Oct; 147(4): 640–9

    Article  Google Scholar 

  35. Haefner HK, Tate JE, McLachlin CM, et al. Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Human Pathol 1995; 26: 147–54

    Article  CAS  Google Scholar 

  36. Zaki I, Dalziel KL, Solomon FA, et al. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin Exp Dermatol 1996; 21(5): 334–7

    Article  PubMed  CAS  Google Scholar 

  37. Buscema J, Stern J, Woodruff JD. The significance of the histologic alterations adjacent to invasive vulvar carcinoma. Am J Obstet Gynecol 1980; 137: 902–9

    PubMed  CAS  Google Scholar 

  38. Zaino RJ, Husseinzadeh N, Nahhas W, et al. Epithelial alterations in proximity to invasive squamous carcinoma of the vulva. Int J Gynecol Pathol 1982; 1: 173–84

    Article  PubMed  CAS  Google Scholar 

  39. Choo YC. Invasive squamous carcinoma of the vulva in young patients. Gynecol Oncol 1982; 13: 158–64

    Article  PubMed  CAS  Google Scholar 

  40. Hacker N, Berek J, Lagasse L, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984; 63: 155–62

    PubMed  CAS  Google Scholar 

  41. Hewitt J. Conditions étiologiques du carcinome invasif d’emblée de la vulve: possibilité d’un traitement prophylactique? J Gynecol Obstet Biologie de la Reprod 1984; 13: 297–303

    Google Scholar 

  42. Borgno G, Micheletti L, Barbero M, et al. Epithelial alterations adjacent to 111 vulvar carcinomas. J Reprod Med 1988; 33: 500–2

    PubMed  CAS  Google Scholar 

  43. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97: 1135–9

    Article  PubMed  CAS  Google Scholar 

  44. Toki T, Kurman R, Park JS, et al. Probable non-papillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991; 10: 107–25

    Article  PubMed  CAS  Google Scholar 

  45. MacLean AB. Precursors of vulval cancers. Curr Obstet Gynecol 1993; 3: 149–56

    Article  Google Scholar 

  46. Ansink AC, Krul M, De Weger R, et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol Oncol 1994; 52: 180–4

    Article  PubMed  CAS  Google Scholar 

  47. Hording U, Junge J, Daugaard S, et al. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994; 52: 241–6

    Article  PubMed  CAS  Google Scholar 

  48. Gomez Rueda N, Garcia A, Vighi S, et al. Epithelial alterations adjacent to invasive squamous carcinoma of the vulva. J Reprod Med 1994; 39: 526–30

    PubMed  CAS  Google Scholar 

  49. Sagerman PM, Choi YJ, Hu Y, et al. Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Gynecol Oncol 1996; 61: 328–32

    Article  PubMed  CAS  Google Scholar 

  50. Vilmer C, Cavelier-Balloy B, Nogues C, et al. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol 1998; 19: 25–31

    PubMed  CAS  Google Scholar 

  51. Derrick EK, Ridley C, Kobza-Black A, et al. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol 2000; 143: 1217–23

    Article  PubMed  CAS  Google Scholar 

  52. Al-Ghamdi A, Freedman D, Miller D, et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol 2002; 84: 94–101

    Article  PubMed  CAS  Google Scholar 

  53. Carli P, Cattaneo A, De Magnis A, et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995 Dec; 4(6): 491–5

    Article  PubMed  CAS  Google Scholar 

  54. Bhattacharjee P, Fatteh SM, Lloyd KL. Squamous cell carcinoma arising in long-standing lichen sclerosus et atrophicus. J Am Geriatr Soc 2004 Feb; 52(2): 319–20

    Article  PubMed  Google Scholar 

  55. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006 Mar; 30(3): 310–8

    PubMed  Google Scholar 

  56. Hart WR, Norris HJ, Helwig EB. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975; 45: 369–77

    PubMed  CAS  Google Scholar 

  57. Jones RW, Sadler L, Grant S, et al. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study. J Reprod Med 2004 Oct; 49(10): 808–11

    PubMed  Google Scholar 

  58. Regauer S, Reich O, Beham-Schmid C. Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am J Pathol 2002 Mar; 160(3): 1035–45

    Article  PubMed  CAS  Google Scholar 

  59. Raspollini MR, Asirelli G, Moncini D, et al. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007 Dec; 197(6): 592, E1-5

    Article  PubMed  Google Scholar 

  60. Di Paola GR, Rueda-Leverone NG, Belardi MG. Lichen sclerosus of the vulva recurrent after myocutaneous graft: a case report. J Reprod Med 1982; 27: 666–8

    PubMed  Google Scholar 

  61. Thomas RH, McGibbon DH, Munro DD. Basal cell carcinoma of the vulva in association with vulval lichen sclerosus et atrophicus. J Royal Soc Med 1985; 78Suppl. 11: 16–8

    Google Scholar 

  62. Rawal N, Saridogan E, Khan N, et al. Leiomyosarcoma of the vulva in association with lichen sclerosus. J Obstet Gynaecol 2005 Jan; 25(1): 87–8

    Article  PubMed  CAS  Google Scholar 

  63. Friedman R, Kopf A, Jones W. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. Am J Dermatopathol 1984; 6: 253–6

    PubMed  Google Scholar 

  64. McAdams AJ, Kistner RW. The relationship of chronic vulvar disease, leukoplakia, and carcinoma in situ to carcinoma of the vulva. Cancer 1958; 11: 740–57

    Article  PubMed  Google Scholar 

  65. Egan CA, Bradley RR, Logsdon VK, et al. Vulvar melanoma in childhood. Arch Dermatol 1997; 133: 345–8

    Article  PubMed  CAS  Google Scholar 

  66. Rosamilia LL, Schwartz JL, Lowe L, et al. Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus. J Am Acad Dermatol 2006 Feb; 54(2 Suppl.): S52–3

    Article  PubMed  Google Scholar 

  67. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007 Dec; 178(6): 2268–76

    Article  PubMed  Google Scholar 

  68. Dalziel KL, Wojnarowska F. Long-term control of vulvar lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993; 38: 25–7

    PubMed  CAS  Google Scholar 

  69. Sinha P, Sorinola O, Luesley DM. Lichen sclerosus of the vulva: long-term steroid maintenance therapy. J Reprod Med 1999; 44: 621–4

    PubMed  CAS  Google Scholar 

  70. Nissi R, Eriksen H, Risteli J, et al. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol Obstet Invest 2007; 63(3): 151–4

    Article  PubMed  CAS  Google Scholar 

  71. Oskay T, Sezer HK, Genc C, et al. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol 2007 May; 46(5): 527–32

    Article  PubMed  Google Scholar 

  72. Assmann T, Becker-Wegerich P, Grewe M, et al. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003; 48: 935–7

    Article  PubMed  Google Scholar 

  73. Virgili A, Lauriola MM, Mantovani L, et al. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol 2007; 87(1): 69–72

    Article  PubMed  CAS  Google Scholar 

  74. Fischer G, Bradford J. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report. J Reprod Med 2007 Apr; 52(4): 329–31

    PubMed  Google Scholar 

  75. Lewis FM, Neill SM. Safety of calcineurin inhibitors in the management of lichen sclerosis. Br J Dermatol 2007; 156: 1362–402

    Article  Google Scholar 

  76. Kyllönen H, Remitz A, Mandelin JM, et al. Effects of 1 year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol 2004; 150: 1174–81

    Article  PubMed  Google Scholar 

  77. Lubach D, Rath J, Kietzmann M. Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology 1995; 190: 51–5

    Article  PubMed  CAS  Google Scholar 

  78. Ayhan A, Guven S, Guvendag Guven ES, et al. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynaecol Obstet 2007 Feb; 96(2): 117–21

    Article  PubMed  CAS  Google Scholar 

  79. Bornstein J, Heifetz S, Kellner Y, et al. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998 Jan; 178 (1 Pt 1): 80–4

    Article  PubMed  CAS  Google Scholar 

  80. Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994 Feb; 30 (2 Pt 1): 225–31

    Article  PubMed  CAS  Google Scholar 

  81. Bulbul Baskan E, Turan H, Tunali S, et al. Open-label trial of cyclosporine for vulvar lichen sclerosus. J Am Acad Dermatol 2007 Aug; 57(2): 276–8

    Article  PubMed  Google Scholar 

  82. Parsad D, Saini R. Oral stanazolol in lichen sclerosus et atrophicus. J Am Acad Dermatol 1998 Feb; 38 (2 Pt 1): 278–9

    Article  PubMed  CAS  Google Scholar 

  83. Wakelin SH, James MP. Extensive lichen sclerosus et atrophicus with bullae and ulceration: improvement with hydroxychloroquine. Clin Exp Dermatol 1994 Jul; 19(4): 332–4

    Article  PubMed  CAS  Google Scholar 

  84. Penneys NS. Treatment of lichen sclerosus with potassium para-aminobenzoate. J Am Acad Dermatol 1984 Jun; 10(6): 1039–42

    Article  PubMed  CAS  Google Scholar 

  85. Kroft EB. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008 Dec; 59(6): 1017–30

    Article  PubMed  Google Scholar 

  86. Beattie PE, Dawe RS, Ferguson J, et al. UVA1 phototherapy for genital lichen sclerosus. Clin Exp Dermatol 2006; 31(3): 343–7

    Article  PubMed  CAS  Google Scholar 

  87. Nayeemuddin F, Yates VM. Lichen sclerosus et atrophicus responding to methotrexate. Clin Exp Dermatol 2008 Aug; 33(5): 651–2

    Article  PubMed  CAS  Google Scholar 

  88. Breech LL, Laufer MR. Surgicel in the management of labial and clitoral hood adhesions in adolescents with lichen sclerosus. J Pediatr Adolesc Gynecol 2000 Feb; 13(1): 21–2

    Article  PubMed  CAS  Google Scholar 

  89. Goldstein AT, Burrows LJ. Surgical treatment of clitoral phimosis caused by lichen sclerosus. Am J Obstet Gynecol 2007 Feb; 196(2): 126.e1-4

    Article  PubMed  Google Scholar 

  90. Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol 2002 Jan; 186(1): 49–52

    Article  PubMed  Google Scholar 

  91. Balasubramaniam P, Lewis FM. Long-term follow-up of patients with lichen sclerosus: does it really happen? [abstract]. J Obstet Gynaecol 2007 Apr; 27(3): 282

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. University of Michigan Center for Vulvar Disease, University of Michigan Hospitals, L 4000 Women’s Hospital, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109, USA

    Natalie A. Saunders &  Hope K. Haefner

Authors
  1. Natalie A. Saunders
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hope K. Haefner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saunders, N.A., Haefner, H.K. Vulvar Lichen Sclerosus in the Elderly. Drugs Aging 26, 803–812 (2009). https://doi.org/10.2165/11316820-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11316820-000000000-00000

Keywords

Search

Navigation